Calcitriol Suppresses Antiretinal Autoimmunity through Inhibitory Effects on the Th17 Effector Response 1
暂无分享,去创建一个
L. Adorini | C. Chan | S. Su | R. Caspi | W. Zhu | D. Luger | P. Silver | J. Tang | R. Zhou | R. Grajewski | Jun Tang | Wei Zhu | Dror Luger | C. Chan | Ru Zhou
[1] L. Adorini,et al. Control of autoimmune diseases by the vitamin D endocrine system , 2008, Nature Clinical Practice Rheumatology.
[2] Y. Iwakura,et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category , 2008, The Journal of experimental medicine.
[3] C. Daniel,et al. Immune Modulatory Treatment of Trinitrobenzene Sulfonic Acid Colitis with Calcitriol Is Associated with a Change of a T Helper (Th) 1/Th17 to a Th2 and Regulatory T Cell Profile , 2008, Journal of Pharmacology and Experimental Therapeutics.
[4] D. Littman,et al. Transcriptional regulation of Th17 cell differentiation. , 2007, Seminars in immunology.
[5] M. McGeachy,et al. The link between IL-23 and Th17 cell-mediated immune pathologies. , 2007, Seminars in immunology.
[6] J. O’Shea,et al. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. , 2007, Seminars in immunology.
[7] R. Nussenblatt,et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 , 2007, Nature Medicine.
[8] S. Su,et al. Autoimmune Uveitis Elicited with Antigen-Pulsed Dendritic Cells Has a Distinct Clinical Signature and Is Driven by Unique Effector Mechanisms: Initial Encounter with Autoantigen Defines Disease Phenotype1 , 2007, The Journal of Immunology.
[9] Bing Li,et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. , 2007, The Journal of allergy and clinical immunology.
[10] R. Kumar,et al. Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: a paradigm for ligand-augmented negative transcriptional regulation. , 2007, Archives of biochemistry and biophysics.
[11] Chen Dong,et al. STAT3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells* , 2007, Journal of Biological Chemistry.
[12] L. Hennighausen,et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. , 2007, Immunity.
[13] C. Doglioni,et al. Treatment of Experimental Autoimmune Prostatitis in Nonobese Diabetic Mice by the Vitamin D Receptor Agonist Elocalcitol1 , 2006, The Journal of Immunology.
[14] C. Mathieu,et al. Immunomodulation by 1,25-dihydroxyvitamin D3: therapeutic implications in hemodialysis and renal transplantation. , 2006, Clinical nephrology.
[15] D. Littman,et al. The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.
[16] K. Mills,et al. A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis , 2006, The Journal of experimental medicine.
[17] S. Iturria,et al. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. , 2006, The Journal of clinical investigation.
[18] A. Rudensky,et al. A function for interleukin 2 in Foxp3-expressing regulatory T cells , 2005, Nature Immunology.
[19] L. Adorini,et al. Inhibition of Acute and Chronic Allograft Rejection in Mouse Models by BXL-628, a Nonhypercalcemic Vitamin D Receptor Agonist , 2005, Transplantation.
[20] K. Kragballe,et al. A Two-Compound Product Containing Calcipotriol and Betamethasone Dipropionate Provides Rapid, Effective Treatment of Psoriasis vulgaris regardless of Baseline Disease Severity , 2005, Dermatology.
[21] M. Cantorna,et al. Vitamin D Receptor-Deficient Mice Fail to Develop Experimental Allergic Asthma , 2004 .
[22] R. Caspi,et al. Rodent models of experimental autoimmune uveitis. , 2004, Methods in molecular medicine.
[23] M. Uskoković,et al. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. , 2004, Journal of cellular biochemistry.
[24] D. Littman,et al. The role of the nuclear hormone receptor RORγt in the development of lymph nodes and Peyer's patches , 2003, Immunological reviews.
[25] M. Cantorna,et al. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells , 2003, Journal of cellular biochemistry.
[26] C. Mathieu,et al. Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3). , 2002, Diabetes.
[27] L. Freedman,et al. 1,25-Dihydroxyvitamin D3 Inhibits IFN-γ and IL-4 Levels During In Vitro Polarization of Primary Murine CD4+ T Cells1 , 2002, The Journal of Immunology.
[28] L. Freedman,et al. 1,25-Dihydroxyvitamin D3 Inhibits IFN- and IL-4 Levels During In Vitro Polarization of Primary Murine CD4 T Cells , 2002 .
[29] H. DeLuca,et al. Vitamin D: its role and uses in immunology 1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] Huub F. J. Savelkoul,et al. 1α,25-Dihydroxyvitamin D3 Has a Direct Effect on Naive CD4+ T Cells to Enhance the Development of Th2 Cells1 , 2001, The Journal of Immunology.
[31] L. Glimcher,et al. Lineage commitment in lymphocytes: controlling the immune response. , 2001, The Journal of clinical investigation.
[32] S. Orencole,et al. Array-based ELISAs for high-throughput analysis of human cytokines. , 2001, BioTechniques.
[33] R. Kumar,et al. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. , 2000, Biochemical and biophysical research communications.
[34] L. Freedman,et al. Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. , 2000, Gene.
[35] L. Adorini,et al. 1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.
[36] H. DeLuca,et al. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. , 2000, Archives of biochemistry and biophysics.
[37] M. Bevan,et al. RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. , 1998, Immunity.
[38] J. Park,et al. Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects. , 1998, Journal of immunology.
[39] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[40] L. Freedman,et al. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo , 1996, Molecular and cellular biology.
[41] A. Billiau,et al. Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice. , 1994, Journal of immunology.
[42] G. Chader,et al. The mouse as a model of experimental autoimmune uveoretinitis (EAU). , 1990, Current eye research.
[43] R. Nussenblatt,et al. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. , 1988, Journal of immunology.